Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Treatment    crawled date : 2021 - 09 - 01    save search

Revance Announces Publication of Results on Static Glabellar Lines With Repeated Treatment of DaxibotulinumtoxinA for Injection From the SAKURA Clinical Program in Dermatologic Surgery
Published: 2021-09-01 (Crawled : 13:15) - biospace.com/
RVNC | $3.67 0.27% 550K twitter stocktwits trandingview |
Health Technology
| | O: -0.15% H: 1.57% C: 1.31%

treatment injection results
Junshi Biosciences and Coherus Announce Completion of Rolling BLA Submission to U.S. FDA for Toripalimab for the Treatment of Nasopharyngeal Carcinoma
Published: 2021-09-01 (Crawled : 13:00) - globenewswire.com
ABBV | News | $168.1 -0.85% 670K twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.44% C: -7.21%
CHRS | $2.11 -3.21% 190K twitter stocktwits trandingview |
Health Technology
| | O: -0.13% H: 1.75% C: 1.0%

treatment fda submission bla submission
ABVC BioPharma Announces New PCT Filings for MDD and ADHD Treatments
Published: 2021-09-01 (Crawled : 13:00) - globenewswire.com
ABVC | $1.35 3.6M twitter stocktwits trandingview |
Wholesale Trade
| | O: 40.0% H: 17.0% C: -11.58%

treatment biopharma adhd
Coherus and Junshi Biosciences Announce Completion of Rolling BLA Submission to U.S. FDA for Toripalimab for the Treatment of Nasopharyngeal Carcinoma
Published: 2021-09-01 (Crawled : 12:15) - globenewswire.com
ABBV | News | $168.1 -0.85% 670K twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.44% C: -7.21%
CHRS | $2.11 -3.21% 190K twitter stocktwits trandingview |
Health Technology
| | O: -0.13% H: 1.75% C: 1.0%

treatment fda submission bla submission
Janssen Announces U.S. FDA Approval of INVEGA HAFYERA™ (6-month paliperidone palmitate), First and Only Twice-Yearly Treatment for Adults with Schizophrenia
Published: 2021-09-01 (Crawled : 12:00) - prnewswire.com
JNJ | News | $147.27 -1.53% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.13% H: 0.49% C: 0.49%

treatment fda schizophrenia fda approval approval
Gainers vs Losers
58% 42%

Top 10 Gainers
CSSE 4 | $0.3686 142.02% 76M twitter stocktwits trandingview |
Consumer Services

CZOO | $11.685 134.17% 7.6M twitter stocktwits trandingview |

BOF | $1.93 64.96% 55M twitter stocktwits trandingview |

AMST | $3.14 57.0% 59M twitter stocktwits trandingview |
Technology Services

LICN | $0.7885 40.8% 11M twitter stocktwits trandingview |

TROO | $1.51 38.53% 5.6M twitter stocktwits trandingview |
Manufacturing

MULN | News | $3.7 35.53% 6.4M twitter stocktwits trandingview |
Information

WHLM | $6.61 30.12% 400K twitter stocktwits trandingview |
Commercial Services

RILY | $27.91 28.5% 8.9M twitter stocktwits trandingview |
Finance

RBBN 4 | $3.25 26.46% 1.5M twitter stocktwits trandingview |
Electronic Technology


Your saved searches
Save your searches and get alerts when important news are released.